| Name | Title | Contact Details |
|---|
Vanteon Corporation is a Fairport, NY-based company in the Business Services sector.
Lawyers Reporting Inc is a West Palm Beach, FL-based company in the Business Services sector.
Tri State Life Safety is a Fort Lauderdale, FL-based company in the Business Services sector.
LanguageLine Solutions, the global leader in innovative language access solutions for more than 30 years, provides the highest quality over-the-phone, LanguageUC® video remote, and onsite interpreting, translation and localization, as well as bilingual and interpreter testing and training. Trusted by more than 25,000 clients to enable their communication in any situation with the growing limited English proficient and the Deaf and Hard-of-Hearing populations, we provide the industry's most dependable access to highly trained and professional interpreters and translators in more than 200 languages, 24/7/365. LanguageLine Solutions facilitates 23,000,000 calls every year; that's a new human connection every 1.5 seconds. - See more at: http://globenewswire.com/news-release/2014/10/10/672368/10102193/en/LanguageLine-Solutions-R-Announces-Information-Technology-Leadership-Change-to-Accelerate-Innovation.html#sthash.U8CKR50p.dpuf
Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.